|
|
Volumn 58, Issue 6, 2019, Pages 953-962
|
|
Clinical significance of Janus Kinase inhibitor selectivity
|
|
Author keywords
DMARDs; Janus Kinase; rheumatoid arthritis; targeted synthetic DMARDs; treatment
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
AZETIDINE DERIVATIVE;
BARICITINIB;
JANUS KINASE INHIBITOR;
PIPERIDINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
SULFONAMIDE;
TOFACITINIB;
HUMAN;
INFLAMMATION;
RHEUMATOID ARTHRITIS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
AZETIDINES;
HUMANS;
INFLAMMATION;
JANUS KINASE INHIBITORS;
PIPERIDINES;
PYRIMIDINES;
PYRROLES;
SULFONAMIDES;
|
|
EID: 85064887539
PISSN: None
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/key339 Document Type: Review |
|
Times cited : (214)
|
|
References (0)
|